Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:
Migrated from Short description of key information:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:
Migrated from Short description of key information:
Trimofix O is regarded as a potential weak skin sensitizer, at the concentration of 25%, with an EC3 value of 20.71. (Kimber et al, 2003).

Justification for classification or non-classification